Cargando…

1629. Herpes Zoster Risk in Immunocompromised Adults in the United States: A Systematic Review

BACKGROUND: The two known primary risk factors for herpes zoster (HZ) are age and immunodeficiency yet estimates of HZ risk by immunocompromising medical condition have not been well characterized. We undertook a systematic review of the literature to estimate HZ risk in six categories of immunocomp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dooling, Kathleen L, Guo, Angela, Pergam, Steven A, McKay, Susannah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809327/ http://dx.doi.org/10.1093/ofid/ofz360.1493

Ejemplares similares

2500. Incidence of Herpes Zoster in the Pre- and Post-Vaccine Era: Do Trends Differ Between Blacks And Whites?
por: Dooling, Kathleen, et al.
Publicado: (2018)

20. Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States
por: Curran, Desmond, et al.
Publicado: (2021)

1461. The Impact of Universal Varicella Vaccination on Herpes Zoster Incidence in the United States
por: Leung, Jessica W, et al.
Publicado: (2022)

914. Incidence of Herpes Zoster and Postherpetic Neuralgia and Herpes Zoster Vaccination in a United States Administrative Claims Database
por: Jain, Purva, et al.
Publicado: (2023)

Multidermatomal Herpes Zoster in immunocompromised patient
por: Park, Keon Woo, et al.
Publicado: (2020)

2284. Ten-Year Effectiveness of Live Virus Herpes Zoster Vaccine
por: Tseng, Hung Fu, et al.
Publicado: (2018)

1629 The Incidence of Clostridium difficile Infection in Hospitalized Patients with Cystic Fibrosis in the United States
por: Deshpande, Abhishek, et al.
Publicado: (2014)

Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Anderson, Tara C., et al.
Publicado: (2022)

1759. Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002–2016
por: Buchan, Sarah, et al.
Publicado: (2019)

Herpes-Zoster-Associated Voiding Dysfunction in an Immunocompromised Patient
por: Alalwan, Adel A, et al.
Publicado: (2020)

07. Recombinant Zoster Vaccine (RZV) Second-Dose Completion in Adults Age 50‒64 Years in the United States
por: Leung, Jessica, et al.
Publicado: (2021)

Assessment of the Potential Herpes Zoster and Post Herpetic Neuralgia Case Avoidance with Vaccination in the United States
por: Patterson, Brandon J, et al.
Publicado: (2017)

Herpes zoster segmental paresis in an immunocompromised breast cancer woman
por: Rastegar, Shirvan, et al.
Publicado: (2015)

Necrotizing Fasciitis Following Herpes Zoster Ophthalmicus in an Immunocompromised Patient
por: Cozzupoli, Grazia Maria, et al.
Publicado: (2019)

Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer
por: Curran, Desmond, et al.
Publicado: (2023)

12. Modeled Impact of the COVID-19 Pandemic and Associated Reduced Adult Vaccinations on Herpes Zoster in the United States
por: La, Elizabeth M, et al.
Publicado: (2021)

4. Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Adults
por: Dagnew, Alemnew F, et al.
Publicado: (2020)

Performance of Zoster Vaccine Live (Zostavax): A Systematic Review of 12 years of Experimental and Observational Evidence
por: Dooling, Kathleen, et al.
Publicado: (2017)

Incidence of Herpes Zoster and Persistent Post-Zoster Pain in Adults With or Without Diabetes in the United States
por: Suaya, Jose A., et al.
Publicado: (2014)

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
por: Dooling, Kathleen L., et al.
Publicado: (2018)

1046 Economic Burden of Herpes Zoster by Age Group in Immunocompetent Patients in the United States
por: Gatwood, Justin, et al.
Publicado: (2014)

Effectiveness of Live Zoster Vaccine in Preventing Herpes Zoster Ophthalmicus (HZO)
por: Aukes, Laurie, et al.
Publicado: (2017)

The Efficacy of Amenamevir for the Treatment of Disseminated Herpes Zoster Complicated with Probable Varicella-zoster Pneumonia in an Immunocompromised Patient
por: Kobayashi, Hiroki, et al.
Publicado: (2021)

2478. Impact of 20 Years of Varicella Vaccination on the Epidemiology of Herpes Zoster in the United States: An Interrupted Time Series Analysis
por: Wolfson, Lara, et al.
Publicado: (2018)

Herpes zoster duplex bilateralis symmetricus in an immunocompromised patient with recent varicella infection
por: Amonchaisakda, Nuntouchaporn, et al.
Publicado: (2021)

2480. Real-World Effectiveness of the Live Zoster Vaccine in Preventing Herpes Zoster: A Systematic Review
por: Saddier, Patricia, et al.
Publicado: (2018)

Herpes Zoster and Recurrent Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2017)

Varicella Zoster Virus-Specific Hyperimmunoglobulin in the Adjuvant Treatment of Immunocompromised Herpes Zoster Patients: A Case Series
por: Terheyden, Patrick, et al.
Publicado: (2023)

Humoral and Cellular Immunogenicity of Zoster Vaccine within One Year after Herpes Zoster
por: Lee, Eunyoung, et al.
Publicado: (2017)

Burden of Herpes Zoster Among Patients with Psoriasis in the United States
por: Singer, David, et al.
Publicado: (2023)

Risk Factors for Herpes Zoster: a Systematic Review and Meta-Analysis
por: Kawai, Kosuke, et al.
Publicado: (2017)

Herpes–Zoster Infection in a Tertiary Hospital in Brazil
por: Antoniolli, Luciana, et al.
Publicado: (2017)

910. Herpes Zoster in Children: A Literature Review
por: Simpson, Chris, et al.
Publicado: (2023)

Herpes Zoster Induced Osteomyelitis in the Immunocompromised Patients: A 10-year Multicenter Study
por: Tabrizi, Reza, et al.
Publicado: (2014)

Post Herpes Zoster Trigeminal Trophic Syndrome in a Child: An Example of Immunocompromised District
por: Caccavale, Stefano, et al.
Publicado: (2016)

Herpes Zoster Induced Alveolar Bone Necrosis in Immunocompromised Patients; Two Case Reports
por: Gholami, Mahdi, et al.
Publicado: (2016)

A clinico-epidemiological multicenter study of herpes zoster in immunocompetent and immunocompromised hospitalized children
por: Hwang, Ji Hyen, et al.
Publicado: (2019)

Herpes-zoster associated urinary retention in a 57-year-old immunocompromised male
por: Au, Vivienne H., et al.
Publicado: (2020)

Herpes Zoster Infection in an Immunocompromised Patient: A Case Report and Review of Corticosteroid’s Role
por: Seixas, Rui, et al.
Publicado: (2022)

Projected risks and health benefits of vaccination against herpes zoster and related complications in US adults
por: Janusz, Cara B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7ojuhl9i5fgj2o5k42t5h54nhh